Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Emerg Infect Dis ; 25(7): 1433-1435, 2019 07.
Article in English | MEDLINE | ID: mdl-31075078

ABSTRACT

African swine fever is one of the most dangerous diseases of swine. We confirmed the 2019 outbreak in Vietnam by real-time reverse transcription PCR. The causative strain belonged to p72 genotype II and was 100% identical with viruses isolated in China (2018) and Georgia (2007). International prevention and control collaboration is needed.


Subject(s)
African Swine Fever/epidemiology , African Swine Fever/history , African Swine Fever/virology , Animals , Asfarviridae/classification , Asfarviridae/genetics , DNA, Viral , Disease Outbreaks , Genes, Viral , Genotype , High-Throughput Nucleotide Sequencing , History, 21st Century , Phylogeny , Sequence Analysis, DNA , Swine
2.
Sci Rep ; 8(1): 2563, 2018 02 07.
Article in English | MEDLINE | ID: mdl-29416087

ABSTRACT

Two sialylated human milk oligosaccharides (SHMOs) 3'-sialyllactose (3'-SL) and 6'-sialyllactose (6'-SL) were accessed for their possible antiviral activity against six different subtypes of thirteen avian influenza (AI) viruses in vitro. 3'-SL exhibited promising antiviral activity against almost all subtypes of tested AI viruses in hemagglutination inhibition assay, whereas 6'-SL showed activity against few selected H1N1, H1N2, and H3N2 subtype strains. 3'-SL has minimum inhibitory concentration values of 15.62 mM or less in more than half of the viruses examined. 3'-SL also showed effective inactivation of H9N2 Korea isolate (A/Chicken/Korea/MS96/1996) at 12.5 mM concentration in Madin Darby Canine Kidney (MDCK) cell line. Thus, 3'-SL was further studied for in vivo study against H9N2 virus in pathogen free chicken experiment models. In vivo study exhibited improved clinical symptoms on H9N2 infected chickens when treated with 3'-SL. Moreover, treating chickens with 3'-SL resulted in complete elimination of H9N2 viruses within 24 h of virus infection (0.8 HAU of H9N2). Indirect ELISA assay confirmed complete wash-out of H9N2 viruses from the colon after neutralization by 3'-SL without entering the blood stream. These in vivo results open up possible applications of 3'-SL for the prevention of AI virus infections in birds by a simple cleansing mechanism.


Subject(s)
Antiviral Agents/pharmacology , Influenza A Virus, H9N2 Subtype/drug effects , Lactose/analogs & derivatives , Milk, Human/chemistry , Oligosaccharides/pharmacology , Animals , Chickens , Dogs , Humans , Lactose/pharmacology , Madin Darby Canine Kidney Cells , Models, Animal , Republic of Korea
3.
J Virol Methods ; 225: 4-8, 2015 Dec 01.
Article in English | MEDLINE | ID: mdl-26342906

ABSTRACT

Porcine epidemic diarrhea virus (PEDV) causes acute diarrhea and dehydration in sucking piglets and has a high mortality rate. An immunochromatography (IC) assay, known as a lateral flow test, is a simple device intended to detect the presence of target pathogens. Here, we developed an IC assay that detected PEDV antigens with 96.0% (218/227) sensitivity and 98.5% (262/266) specificity when compared with real-time reverse transcriptase (RT)-PCR using FAM-labeled probes based on sequences from nucleocapsid genes. The detection limits of the real-time RT-PCR and IC assays were 1×10(2) and 1×10(3) copies, respectively. The IC assay developed herein did not detect non-specific reactions with other viral or bacterial pathogens, and the assay could be stored at 4°C or room temperature for 15 months without affecting its efficacy. Thus, the IC assay may result in improved PED detection and control on farms, and is a viable alternative to current diagnostic tools for PEDV.


Subject(s)
Chromatography, Affinity/methods , Coronavirus Infections/veterinary , Porcine epidemic diarrhea virus/isolation & purification , Swine Diseases/diagnosis , Swine Diseases/virology , Animals , Antigens, Viral/analysis , Coronavirus Infections/diagnosis , Coronavirus Infections/virology , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Sensitivity and Specificity , Swine
4.
J Vet Med Sci ; 73(1): 55-63, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20798477

ABSTRACT

Pandemic (H1N1) 2009 influenza has spread throughout the world since April 2009 and has caused many human deaths since its first report in humans. Pandemic (H1N1) 2009 influenza virus was first identified in a Canadian pig herd in April 2009 and has been reported in more than ten countries, including Korea. We developed a one-step multiplex reverse transcriptase polymerase chain reaction (RT-PCR) assay based on the matrix gene that discriminates pandemic (H1N1) 2009 influenza virus from endemic swine influenza viruses. The sensitivity of this assay was 100 copies of in vitro-transcribed target RNA and 0.01 tissue culture infective dose (TCID(50)/ml) of virus and was as high as those of conventional influenza A virus common matrix reverse transcriptase PCR assays and real-time reverse transcriptase PCR assays (1 to 200 copies) developed for detecting pandemic (H1N1) 2009 influenza viruses from human and pig samples. This one-step multiplex RT-PCR assay would be a good tool in monitoring pandemic (H1N1) 2009 influenza virus among pig herds on a regular basis.


Subject(s)
Influenza A Virus, H1N1 Subtype/isolation & purification , Orthomyxoviridae Infections/veterinary , Pandemics , Reverse Transcriptase Polymerase Chain Reaction/methods , Animals , Cell Line , Chick Embryo , Dogs , Humans , Influenza, Human/epidemiology , Influenza, Human/virology , Orthomyxoviridae Infections/epidemiology , Orthomyxoviridae Infections/virology , Sensitivity and Specificity , Specific Pathogen-Free Organisms , Swine
5.
Int J Neurosci ; 118(10): 1384-99, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18788024

ABSTRACT

KI0477959 (Herbkines) has been used for the purpose of development of physical strength in wasting diseases, like cancer. In the present study, apoptosis-inducing activities of butanol fraction of KI0477959 were studied in human leukemia cell line, HL-60 cells. KI0477959 increased cytotoxicity but had less effect on human peripheral blood mononuclear cells. KI0477959-induced apoptosis was accompanied by activation of caspase-3 and specific proteolytic cleavage of poly-ADP-ribose polymerase. Increased apoptosis was reduced by treatment with p38 and extracellular signal-regulated protein kinase (ERK) inhibitors. These results suggest that KI0477959 induces apoptosis through activation of caspase-3, p38, and ERK in HL-60 cells.


Subject(s)
Apoptosis/drug effects , Caspase 3/metabolism , Drugs, Chinese Herbal/pharmacology , Plant Extracts/pharmacology , Analysis of Variance , Cell Cycle/drug effects , Cell Survival/drug effects , Collagen Type XI/metabolism , DNA Fragmentation/drug effects , Drug Combinations , Drugs, Chinese Herbal/chemistry , HL-60 Cells , Humans , Leukemia/metabolism , Leukemia/pathology , Medicine, Korean Traditional , Mitogen-Activated Protein Kinase Kinases/metabolism , Plant Extracts/chemistry , Time Factors
6.
J Neuroimmunol ; 163(1-2): 84-91, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15885310

ABSTRACT

Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis. The iron-chelator desferrioxamine (DFX) increased the expression of hypoxia-inducible factor (HIF)-1alpha in the hair cell line, HEI-OC1. The increased VEGF production by DFX was inhibited by iron. DFX also induced the activation of mitogen-activated protein kinase (MAPK) on HEI-OC1. The increased VEGF production by DFX was inhibited by a specific inhibitor of MAPK. In addition, DFX induced the VEGF production and HIF-1alpha stabilization in vivo. These results indicate that VEGF production is regulated via MAPK and HIF-1alpha under hypoxic condition in the inner ear.


Subject(s)
DNA-Binding Proteins/physiology , Ear, Inner/metabolism , Mitogen-Activated Protein Kinases/physiology , Nuclear Proteins/physiology , Stress, Physiological/metabolism , Stress, Physiological/physiopathology , Transcription Factors/physiology , Vascular Endothelial Growth Factor A/biosynthesis , Animals , Cell Hypoxia/physiology , Cell Line , Cells, Cultured , Enzyme Activation/physiology , Hypoxia-Inducible Factor 1 , Hypoxia-Inducible Factor 1, alpha Subunit , Mice , Mice, Transgenic , Vascular Endothelial Growth Factor A/genetics
7.
J Pharmacol Sci ; 97(1): 138-45, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15655286

ABSTRACT

Gagam-whanglyun-haedoktang (GWH) is a newly designed herbal drug formula based on the traditional oriental pharmacological knowledge for the purpose of treating tumorous diseases. Apoptosis is an evolutionarily conserved suicide program residing in cells. In the present study, apoptosis inducing activities of the decocted water extract of GWH were studied. Results of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay showed that GWH had a strong cytotoxic effect on HL-60 cells. The number of live cells was less than 20% after exposure to 1 mg/ml GWH for 48 h. GWH increased cytotoxicity of HL-60 cells in a dose- and time-dependent manner. The percentage of apoptotic cells by flow cytometric analysis of the DNA-stained cells increased to 28%, 31%, and 37% at 24 h and to 37%, 44%, and 81% at 48 h after treatment with 0.01, 0.1, and 1 mg/ml GWH, respectively. DNA fragmentation also occurred in apoptosis and was characterized by a ladder pattern on agarose gel. In addition, GWH increased the secretion of tumor necrosis factor-alpha. GWH-induced apoptosis was accompanied by activation of caspase-3. These results suggest that GWH induces activation of caspase-3 and eventually leads to apoptosis.


Subject(s)
Caspases/metabolism , DNA Fragmentation , Enzyme Activation/drug effects , Medicine, East Asian Traditional , Plant Preparations/adverse effects , Caspase 3 , Caspases/adverse effects , Cell Cycle/drug effects , Cell Survival/drug effects , Cell Survival/physiology , Dose-Response Relationship, Drug , Enzyme-Linked Immunosorbent Assay , Flow Cytometry/methods , HL-60 Cells , Humans , Time Factors , Tumor Necrosis Factor-alpha/metabolism
8.
Clin Chim Acta ; 337(1-2): 77-84, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14568183

ABSTRACT

BACKGROUND: The herbal formulation, Allergina, has long been used for various diseases. It is known to have an anti-microbial and anti-virus activity. However, it is still unclear how Allergina has these effects in experimental models. We investigated the effect of Allergina on the proliferation of T cell and production of cytokines in human T-cell line, MOLT-4 cells, and mouse peritoneal macrophages. METHODS: The MOLT-4 cells were cultured for 24 h in the presence or absence of Allergina. Allergina significantly increased the cell viability by 26.9+/-5.4% (P<0.05) and interleukin (IL)-2, IL-4 and interferon (IFN)-gamma production compared with media control (about 4-fold for IL-2, 2.5-fold for IL-4 and 3.4-fold for IFN-gamma, P<0.05). Maximal effective concentration of Allergina was 1 mg/ml for IL-2 and, 0.01 mg/ml for IL-4 and IFN-gamma. Allergina alone or Allergina plus recombinant IFN-gamma (rIFN-gamma) increased the production of tumor necrosis factor (TNF)-alpha, but Allergina decreased the production of TNF-alpha on rIFN-gamma plus LPS-stimulated macrophages. In addition, Allergina increased the production of IL-12 on mouse peritoneal macrophages and peripheral blood mononuclear cells. CONCLUSION: Allergina may have an immune-enhancement effect through the cytokine production.


Subject(s)
Adjuvants, Immunologic/pharmacology , Plant Extracts/pharmacology , Animals , Cell Division/drug effects , Cell Line, Tumor , Cell Survival/drug effects , Concanavalin A/pharmacology , Dose-Response Relationship, Drug , Humans , Interferon-gamma/analysis , Interferon-gamma/metabolism , Interferon-gamma/pharmacology , Interleukin-12/analysis , Interleukin-12/metabolism , Interleukin-2/analysis , Interleukin-2/metabolism , Interleukin-4/analysis , Interleukin-4/metabolism , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/metabolism , Lipopolysaccharides/pharmacology , Macrophages, Peritoneal/cytology , Macrophages, Peritoneal/drug effects , Macrophages, Peritoneal/metabolism , Mice , T-Lymphocytes/drug effects , T-Lymphocytes/metabolism , Thioglycolates/pharmacology , Tumor Necrosis Factor-alpha/analysis , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL